Pain monitoring devices are designed to assess pain levels using physiological signals such as heart rate variability and neural responses. They help clinicians measure pain more objectively.
These devices support improved pain management strategies and personalized treatment planning in clinical settings.
FAQsQ1: How do these devices work?
A1: By analyzing biological pain indicators.
Artificial intelligence (AI) is playing a transformative role in the early detection of cancer, helping doctors identify disease at stages when treatment is most effective. Early diagnosis is critical because many cancers show minimal symptoms in their initial phases, making timely detection difficult using traditional methods alone.
AI for early cancer diagnosis refers to intelligent computer systems that analyze medical data—including imaging scans, laboratory results, genetic information, and patient histories—to identify signs of cancer before symptoms become severe. These systems use machine learning and deep learning algorithms trained on large datasets to recognize subtle disease patterns invisible to the human eye.
AI can process complex multimodal medical information and automatically flag individuals who may require further medical investigation or screening, improving referral and diagnostic workflows.
Antimicrobial therapeutics are medications and treatment strategies used to fight infections caused by microbes—which include bacteria, viruses, fungi, and parasites. These therapies help manage diseases ranging from simple bacterial infections like strep throat to severe, life-threatening conditions such as sepsis or invasive fungal diseases. By targeting harmful pathogens, antimicrobial therapeutics support recovery, prevent disease spread, and save lives.
Antimicrobial agents are substances that kill or inhibit the growth of microorganisms. Depending on the type of microbe targeted, they are classified as:
